Icon Legend

This session is not on your agenda.

This session is on your agenda. Click again to remove it.

Presentation Icons

ACVIM Resident Research Award Eligible

Additional Fees May Be Required

By Invite Only

Capturing for On Demand

Cardiology Research Abstract Award Eligible

ERC Approved Lecture for ACVIM Residency

Poster

Livestream

One Health

Pre-Registration Required

Research Abstract

Specialty Symposium

ACVIM Resident Research Award Winner

Cardiology Research Abstract Award Winner

262 Views

Evaluation Video ViewAttendees 12

To Earn CE for this session: Watch the on-demand recording in its entirety, then click here to complete the CE quiz for this session.

Oncology

Adrenal Tumor Management: Radiation Oncology vs. Medical Oncology Perspectives

Saturday, June 13, 2026

10:20 AM - 11:20 AM PT

Location: Summit SCC, Room 320

CE: 1.0 Medical Hours

Primary Presenter(s)

Jackie M. Wypij, DVM, MS, DACVIM (O) (she/her/hers)

Associate Veterinarian
BluePearl
Sandy Springs, Georgia, United States

Co-Presenter(s)

Lauren Fout, MVB, DACVR (RO) (she/her/hers)

Radiation Oncologist
BluePearl
Sandy Springs, Georgia, United States

Disclosure(s):

Lauren Fout, MVB, DACVR (RO): No financial relationships to disclose

Presentation Description / Summary: This interactive session explores cutting-edge treatment options for canine adrenal gland tumors, featuring insights from both medical and radiation oncology perspectives. Topics will include stereotactic radiation therapy, chemotherapy, and emerging therapeutic modalities. The lecture will incorporate case-based discussions, audience polling, and opportunities for interactive dialogue to enhance clinical decision-making.

Learning Objectives:

Upon completion, participants will be able to correlate clinical symptoms & imaging findings across different adrenal gland tumor types.
Upon completion, participants will be able to describe initial treatment options for benign & malignant adrenal gland tumors including .surgery and medical management.
Upon completion, participants will be able to identify patient candidates for advanced therapy such as radiation or chemotherapy.